Literature DB >> 20377671

Marked papillary dermal edema--an unreliable discriminator between polymorphous light eruption and lupus erythematosus or dermatomyositis.

Laura B Pincus1, Philip E LeBoit, Deborah S Goddard, Raymond J Cho, Timothy H McCalmont.   

Abstract

BACKGROUND: The clinical differential diagnosis of photo-distributed papules and plaques includes polymorphous light eruption (PMLE) and lupus erythematosus (LE). These entities share many histopathological features. However, in most contemporary textbooks, a broad band of papillary dermal edema is reported to be characteristic of PMLE and not seen in LE. Nonetheless, older reports describe papillary dermal edema in LE, including acute cutaneous LE (ACLE) in patients with systemic LE (SLE) and early lesions of discoid lupus erythematosus (DLE). Older reports also describe papillary dermal edema in microscopic sections of dermatomyositis (DM).
METHODS: Retrospective review.
RESULTS: Nine cases of LE (including two patients with acute lesions of SLE, six with DLE and one unclassifiable) and three cases of DM were identified in which sections showed striking papillary dermal edema. Attributes of chronicity, such as epidermal atrophy, follicular plugging and basement membrane thickening, were present concurrently in many sections.
CONCLUSIONS: Marked papillary dermal edema does not reliably distinguish PMLE from LE as it can be seen in ACLE, early and late lesions of DLE and DM. This phenomenon has been underemphasized in recent reports and textbooks. Furthermore, papillary dermal edema in chronic lesions of DLE has not been previously reported.

Entities:  

Mesh:

Year:  2010        PMID: 20377671     DOI: 10.1111/j.1600-0560.2010.01516.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  Characterization of clinical photosensitivity in cutaneous lupus erythematosus.

Authors:  Kristen Foering; Aileen Y Chang; Evan W Piette; Andrew Cucchiara; Joyce Okawa; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2013-05-03       Impact factor: 11.527

2.  CD123 immunoexpression in cutaneous lupus erythematosus, polymorphous light eruption, pityriasis rosea, and mycosis fungoides.

Authors:  Ebru Karagun; Mehmet Gamsizkan; Seyma Buyucek; Sinem Coskun
Journal:  Postepy Dermatol Alergol       Date:  2022-01-07       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.